Loading...
Derniers dépôts
-
Julia Gilhodes, Adèle Meola, Bastien Cabarrou, Guillaume Peyraga, Caroline Dehais, et al.. A Multigene Signature Associated with Progression-Free Survival after Treatment for IDH Mutant and 1p/19q Codeleted Oligodendrogliomas. Cancers, 2023, 15 (12), pp.3067. ⟨10.3390/cancers15123067⟩. ⟨hal-04207099⟩
-
-
-
Maria Escala-Garcia, Sander Canisius, Renske Keeman, Jonathan Beesley, Hoda Anton-Culver, et al.. Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis. Scientific Reports, 2021, 11 (1), pp.19787. ⟨10.1038/s41598-021-99409-3⟩. ⟨hal-04211353⟩
-
-
-
-
-
-
Arie Brinkman, Serena Nik-Zainal, Femke Simmer, F. Germán Rodríguez-González, Marcel Smid, et al.. Partially methylated domains are hypervariable in breast cancer and fuel widespread CpG island hypermethylation. Nature Communications, 2019, 10 (1), pp.1749. ⟨10.1038/s41467-019-09828-0⟩. ⟨hal-04210659⟩
-
Benoîte Mery, Christine Ménétrier-Caux, Laure Montané, Pierre-Etienne Heudel, Isabelle Ray-Coquard, et al.. Pembrolizumab in Lymphopenic Metastatic Breast Cancer Patients Treated with Metronomic Cyclophosphamide: A Clinical and Translational Prospective Study. Breast Cancer, 2023, 15, pp.311 - 325. ⟨10.2147/bctt.s400055⟩. ⟨hal-04210158⟩
-
-
-
Emmanuelle Kuhn, Philippe Caron, Brigitte Delemer, Isabelle Raingeard, Herve Lefebvre, et al.. Pegvisomant in combination or pegvisomant alone after failure of somatostatin analogs in acromegaly patients: an observational French ACROSTUDY cohort study (September, 10.1007/s12020-020-02501-3, 2020). Endocrine, 2020, 71 (1), pp.265. ⟨10.1007/s12020-020-02532-w⟩. ⟨hal-03555792⟩
-
Nombre de documents
986
Nombre de notices
1 414
Répartition par type de documents